| Purity: | 98.5% |
|---|---|
| Type: | Central Nervous System Agents |
| Place of Origin: | China (Mainland) |
| CAS No.: | 1744-22-5 |
Quick Details
Specifications
Riluzole (Rilutek) is a used to treat and is marketed by . It delays the onset of -dependence or in selected and may increase survival by approximately two to three months. There has been some evidence to show that higher doses might produce more significant improvements in ALS patients but at almost ￡6 (US$10) per tablet it is at risk of being prohibitively expensive given the modest benefit to patients. One study in the Netherlands found that riluzole is metabolized differently by males and females, and its levels in are decreased in patients who smoke or take . A review states a 9% gain in the probability of surviving one year.